2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Nature continues to show that our own body can produce cells that can modify and treat a variety of conditions, including autoimmune diseases like MS. Technology allows for the isolation, purification and modification of cells to exploit their various properties. In this session …
Continue reading “Emerging Cell-based Therapies in Multiple Sclerosis”
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE People living with advanced multiple sclerosis (MS) experience increasing disability, complex symptom burden, and heightened risk of fragmentation or disengagement from care at a time when coordinated support is essential. With the field’s emphasis on disease modification and disability …
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE OCT (optical coherence tomography) has significantly advanced the clinical practice of neuro-ophthalmology, including the care of patients with demyelinating disease. OCT is a non-invasive, reliable, financially accessible technique for visualizing structures in the eye including the retinal nerve fiber layer (RNFL) and ganglion cell-inner …
Continue reading “OCT Across the Spectrum of Demyelinating Disease”